Chinese university conducts trials to launch new Covid-19 drug
Category: #health  | By Mateen Dalal  | Date: 2020-05-21 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Chinese university conducts trials to launch new Covid-19 drug

Scientists at Peking University in China have successfully conducted tests for a new drug which they claim could help in containing the coronavirus pandemic. Since its outbreak in China, the disease continues to be a massive challenge for scientists and researchers across international borders.

The newly developed drug has been successful in trials at animal stage by reducing viral load in infected mice by 2,500 within a period of five days, claims Sunney Xie, Director of Peking University’s Beijing Advanced Innovation Center for Genomics. The drug uses neutralizing antibodies isolated by Xie’s team from the blood of 60 recovered patients. The team’s research study claims that the use of anti-bodies provides a possible cure for the disease and also shortens the time taken for recovery.

The development process of the drug forms part of single-cell genomics and is not based on immunology or virology, asserts Xie. He has further added that the team expects the drug to be ready for use later in the year to contain any potential outbreak.

A Chinese health official had reported last week that the country has five potential vaccines ready to be tested at the human stage.

Scientists across the world have indicated that plasma could be an effective alternative for treating coronavirus. So far, more than 700 infected people in China have undergone plasma therapy with good therapeutic effects. However, as the supply of plasma is limited, the team at Peking University has focused on 14 neutralizing antibodies that could go for immediate mass-production.

Xie has further explained that the injection of mice with neutralizing antibodies before infection with virus has restrained them from getting infected. The new drug may offer a short-term protection of a few weeks to medical workers which could hopefully be extended to a few months, says Xie.

As of now, scientists worldwide have been working upon more than 100 vaccines. The team at Peking hopes that the new drug could be faster and efficient in its efforts to contain the pandemic.

 

Source Credits:https://economictimes.indiatimes.com/news/international/world-news/scientists-in-china-believe-new-drug-can-stop-pandemic-without-vaccine/articleshow/75838236.cms

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Microsoft investigates Teams and Outlook outage that left users disrupted

Microsoft investigates Teams and Outlook outage that left users disrupted

By Mateen Dalal

Microsoft, the U.S.-based technology frontrunner, reportedly investigating an outage that prevented thousands of customers from accessing services like Teams and Outlook. Apparently, the tech giant did not disclose the number of users that were im...

UK: Budget & basic items’ cost in supermarkets soar 20.3% in December

UK: Budget & basic items’ cost in supermarkets soar 20.3% in December

By Mateen Dalal

Britishers who rely on the budget-friendly aisles of supermarkets reportedly saw the biggest increases in food prices in the months leading up to Christmas, significantly outpacing those for luxury as well as premium brands, as per a survey. Accor...

Sun Cable shuts as $21B solar project to power S’pore hangs in balance

Sun Cable shuts as $21B solar project to power S’pore hangs in balance

By Mateen Dalal

Sun Cable, the Singapore-based solar energy company, has reportedly entered voluntary administration, despite the financial support it received from billionaire investors. The company was supposed to be working on a A$30 billion (US$21 billion) solar...